Corrigendum to: Screening and Identification of Distant Metastasis-Related Differentially Expressed Genes in Human Squamous Cell Lung Carcinoma (The Anatomical Record: Advances in Integrative Anatomy and Evolutionary Biology, (2012), 295, 5, (748-757), 10.1002/ar.22441);Screening and identification of distant metastasis-related differentially expressed genes in human squamous cell lung carcinoma

Anatomical Record

Volumn 295, Issue 5, 2012, Pages 748-757

  Wang, Na ^a,b,c   Zhou, Fachen ^a,c   Xiong, Hai ^a,c   Du, Sha ^a,c   Ma, Jianwei ^c,d   Okai, Issac ^a,c   Wang, Jian ^b,c   Suo, Jing ^a,c   Hao, Lihong ^a,c   Song, Yang ^a,c   Hu, Jun ^a,c   Shao, Shujuan ^a,c  

^a DALIAN MEDICAL UNIVERSITY   (China)

^b DALIAN UNIVERSITY   (China)

^c Liaoning Province Key Laboratory for Hydrobiology   (China)

^d Dalian Youyi Hospital   (China)

Author keywords

Differentially expressed genes; Lung cancer; Metastasis; Microarray; Squamous cell carcinoma

Indexed keywords

ADENYLATE CYCLASE 8; AMELOTIN; ARACHIDONATE 12 LIPOXYGENASE; BCL 2 LIKE 10 PROTEIN; BETA ACTIN; BUDDING UNINHIBITED BY BENZIMIDAZOLES 1 HOMOLOG BETA PROTEIN; COLLAGEN TYPE 7 ALPHA1; CONTACTIN ASSOCIATED PROTEIN LIKE 3; CONTACTIN ASSOCIATED PROTEIN LIKE 3B; CYCLIN DEPENDENT KINASE INHIBITOR 2A; DELETED IN MALIGNANT BRAIN TUMORS 1 PROTEIN; FIBRONECTIN TYPE III AND SPRY DOMAIN CONTAINING 1 PROTEIN; FUCOSYLTRANSFERASE 3; GAP JUNCTIONAL INTERCELLULAR COMMUNICATION PROTEIN; HAPTOGLOBIN; NAPSIN A ASPARTIC PEPTIDASE; NERVE CELL ADHESION MOLECULE; NEUTROPHIL GELATINASE ASSOCIATED LIPOCALIN; PDZK1 INTERACTING PROTEIN 1; PHOSPHOPROTEIN PHOSPHATASE 2; PROTEIN; PROTOCADHERIN 19; PROTOCADHERIN 21; SECRETED FRIZZLED RELATED PROTEIN 1; SIALIC ACID BINDING IG LIKE LECTIN 5; TRANSMEMBRANE PROTEASE SERINE 2; TUMOR NECROSIS FACTOR SUPERFAMILY MEMBER 18 PROTEIN; UNCLASSIFIED DRUG; WNT PROTEIN;

ADULT; AGED; APOPTOSIS; ARTICLE; CANCER PROGNOSIS; CELL ADHESION; CELL CYCLE; CELL CYCLE REGULATION; CLINICAL ARTICLE; CONTROLLED STUDY; DISTANT METASTASIS; DNA MICROARRAY; DOWN REGULATION; FOLLOW UP; GENE EXPRESSION; HUMAN; HUMAN TISSUE; LUNG SQUAMOUS CELL CARCINOMA; PRIORITY JOURNAL; REAL TIME POLYMERASE CHAIN REACTION; SIGNAL TRANSDUCTION; UPREGULATION;

EID: 84862828136     PISSN: 19328486     EISSN: 19328494     Source Type: Journal    
DOI: 10.1002/ar.24296     Document Type: Erratum

References (47)

1. Aviel-Ronen S, Lau SK, Pintilie M. 2008. Glypican-3 is overexpressed in lung squamous cell carcinoma, but not in adenocarcinoma. Mod Pathol 21: 817-825.
2. Betz C, Papadopoulos T, Buchwald J, Dämmrich J, Müller-Hermelink HK. 1995. Surfactant protein gene expression in metastatic and micrometastatic pulmonary adenocarcinomas and other non-small-cell lung carcinomas: detection by reverse trarscriptase-polymerase chain reaction. Cancer Res 55: 4283-4286.
3. Bi X, He H, Ye Y, Dai Q, Han Z, Liang Y, Zhong W. 2010. Association of TMPRSS2 and KLK11 gene expression levels with clinical progression of human prostate cancer. Med Oncol 27: 145-151.
4. Bodenstine TM, Vaidya KS, Ismail A, Beck BH, Cook LM, Diers AR, Landar A, Welch DR. 2010. Homotypic gap junctional communication associated with metastasis suppression increases with PKA activity and is unaffected by PI3K inhibition. Cancer Res 70: 10002-10011.
5. Boye E, Skjølberg HC, Grallert B. 2009. Checkpoint regulation of DNA replication. Methods Mol Biol 521: 55-70.
6. Chu ST, Lin HJ, Huang HL, Chen YH. 1998. The hydrophobic pocket of 24p3 protein from mouse uterine luminal fluid: fatty acid and retinol binding activity and predicted structural similarity to lipocalins. J Pept Res 52: 390-397.
7. Cowland JB, Borregaard N. 1997. Molecular characterization and pattern of tissue expression of the gene for neutrophil gelatinase-associated lipocalin from humans. Genomics 45: 17-23.
8. D'Arrigo A, Belluco C, Ambrosi A, Digito M, Esposito G, Bertola A, Fabris M, Nofrate V, Mammano E, Leon A, Nitti D, Lise M. 2005. Metastatic transcriptional pattern revealed by gene expression profiling in primary colorectal carcinoma. Int J Cancer 115: 256-262.
9. Devireddy LR, Teodoro JG, Richard FA, Green MR. 2001. Induction of apoptosis by a secreted lipocalin that is transcriptionally regulated by IL-3 deprivation. Science 293: 829-834.
10. Goetz DH, Holmes MA, Borregaard N, Bluhm ME, Raymond KN, Strong RK. 2002. The neutrophil lipocalin NGAL is a bacteriostatic agent that interferes with siderophoremediated iron acquisition. Mol Cell 10: 1033-1043.
11. Guijarro MV, Castro ME, Romero L, Moneo V, Carnero A. 2007a. Large scale genetic screen identifies MAP17 as protein bypassing TNF-induced growth arrest. J Cell Biochem 101: 112-121.
12. Guijarro MV, Leal JF, Blanco-Aparicio C, Alonso S, Fominaya J, Lleonart M, Castellvi J, Ramon y Cajal S, Carnero A. 2007b. MAP17 enhances the malignant behavior of tumor cells through ROS increase. Carcinogenesis 28: 2096-2104.
13. Guijarro MV, Leal JF, Fominaya J, Blanco-Aparicio C, Alonso S, Lleonart M, Castellvi J, Ruiz L, Ramon Y Cajal S, Carnero A. 2007c. MAP17 overexpression is a common characteristic of carcinomas. Carcinogenesis 28: 1646-1652.
14. Guijarro MV, Link W, Rosado A, Leal JF, Carnero A. 2007d. MAP17 inhibits Myc-induced apoptosis through PI3K/AKT pathway activation. Carcinogenesis 28: 2443-2450.
15. Heighway J, Knapp T, Boyce L, Brennand S, Field JK, Betticher DC, Ratschiller D, Gugger M, Donovan M, Lasek A, Rickert P. 2002. Expression profiling of primary non-small cell lung cancer for target identification. Oncogene 21: 7749-7763.
16. Hummerich L, Müller R, Hess J, Kokocinski F, Hahn M, Fürstenberger G, Mauch C, Lichter P, Angel P. 2006. Identification of novel tumour-associated genes differentially expressed in the process of squamous cell cancer development. Oncogene 25: 111-121.
17. Huschtscha LI, Moore JD, Noble JR, Campbell HG, Royds JA, Braithwaite AW, Reddel RR. 2009. Normal human mammary epithelial cells proliferate rapidly in the presence of elevated levels of the tumor suppressors p53 and p21(WAF1/CIP1). J Cell Sci 122: 2989-2995.
18. Inamura K, Shimoji T, Ninomiya H, Hiramatsu M, Okui M, Satoh Y, Okumura S, Nakagawa K, Noda T, Fukayama M, Ishikawa Y. 2007. A metastatic signature in entire lung adenocarcinomas irrespective of morphological heterogeneity. Human Pathol 38: 702-709.
19. Kalluri R, Neilson EG. 2003. Epithelial-mesenchymal transition and its implications for fibrosis. J Clin Invest 112: 1776-1784.
20. Khan J, Saal LH, Bittner ML, Chen Y, Trent JM, Meltzer PS. 1999. Expression profiling in cancer using cDNA microarrays. Electrophoresis 20: 223-229.
21. Kolkenbrock H, Hecker-Kia A, Orgel D, Kinawi A, Ulbrich N. 1996. Progelatinase B forms from human neutrophils. Complex formation of monomer/lipocalin with TIMP-1. Biol Chem 377: 529-533.
22. Kubben FJ, Sier CF, Hawinkels LJ, Tschesche H, van Duijn W, Zuidwijk K, van der Reijden JJ, Hanemaaijer R, Griffioen G, Lamers CB, Verspaget HW. 2007. Clinical evidence for a protective role of lipocalin-2 against MMP-9 autodegradation and the impact for gastric cancer. Eur J Cancer 43: 1869-1876.
23. Lang JM, Shennan M, Njauw JC, Luo S, Bishop JN, Harland M, Hayward NK, Tucker MA, Goldstein AM, Landi MT, Puig S, Gruis NA, Bergman W, Bianchi-Scarra G, Ghiorzo P, Hogg D, Tsao H. 2011. A flexible multiplex bead-based assay for detecting germline CDKN2A and CDK4 variants in melanoma-prone kindreds. J Invest Dermatol 131: 480-486.
24. Lee CC, Ho HC, Lee MS, Hung SK, Yu CC, Su YC. 2010. Expression of haptoglobin predicts recurrence in head and neck squamous cell carcinoma. Clin Chim Acta 411: 1116-1121.
25. Leithe E, Sirnes S, Omori Y, Rivedal E. 2006. Downregulation of gap junctions in cancer cells. Crit Rev Oncog 12: 225-256.
26. Li J, Fan Y, Chen J, Yao KT, Huang ZX. 2010. Microarray analysis of differentially expressed genes between nasopharyngeal carcinoma cell lines 5-8F and 6-10B. Cancer Genet Cytogenet 196: 23-30.
27. Livak KJ, Schmittgen TD. 2001. Analysis of relative gene expression data using real-time quantitative PCR and the 2-ΔΔCT methods. Methods 25: 402-408.
28. Manton KJ, Douglas ML, Netzel-Arnett S, Fitzpatrick DR, Nicol DL, Boyd AW, Clements JA, Antalis TM. 2005. Hypermethylation of the 5′ CpG island of the gene encoding the serine protease Testisin promotes its loss in testicular tumorigenesis. Br J Cancer 92: 760-769.
29. Marchetti A, Tinari N, Buttitta F, Chella A, Angeletti CA, Sacco R, Mucilli F, Ullrich A, Iacobelli S. 2002. Expression of 90K (Mac-2 BP) correlates with distant metastasis and predicts survival in stage I non-small cell lung cancer patients. Cancer Res 62: 2535-2539.
30. Ramaswamy S, Ross KN, Lander ES, Golub TR. 2003. A molecular signature of metastasis in primary solid tumors. Nat Genet 33: 49-54.
31. Reed SI. 1997. Control of the G1/S transition. Cancer Surv 29: 7-23.
32. Ross DT, Scherf U, Eisen MB, Perou CM, Rees C, Spellman P, Iyer V, Jeffrey SS, Van de Rijn M, Waltham M, Pergamenschikov A, Lee JC, Lashkari D, Shalon D, Myers TG, Weinstein JN, Botstein D, Brown PO. 2000. Systematic variation in gene expression patterns in human cancer cell lines. Nat Genet 24: 227-235.
33. Soiland H, Janssen EA, Kørner H, Varhaug JE, Skaland I, Gudlaugsson E, Baak JP, Soreide JA. 2009. Apolipoprotein D predicts adverse outcome in women P70 years with operable breast cancer. Breast Cancer Res Treat 113: 519-528.
34. Soto JL, Cabrera CM, Serrano S, Lpez-Nevot MA. 2005. Mutation analysis of genes that control the G1/S cell cycle in melanoma: TP53, CDKN1A, CDKN2A, and CDKN2B. BMC Cancer 5: 36-44.
35. Stoesz SP, Friedl A, Haag JD, Lindstrom MJ, Clark GM, Gould MN. 1998. Heterogeneous expression of the lipocalin NGAL in primary breast cancers. Int J Cancer 79: 565-572.
36. Tanney A, Oliver GR, Farztdinov V, Kennedy RD, Mulligan JM, Fulton CE, Farragher SM, Field JK, Johnston PG, Harkin DP, Proutski V, Mulligan KA. 2008. Generation of a non-small cell lung cancer transcriptome microarray. BMC Med Genom 1: 20-31.
37. Thlery JP. 2002. Epithelial-mesenchymal transitions in tumour progression. Nat Ren Cancer 2: 442-454.
38. Van Gelder RN, von Zastrow ME, Yool A. 1990. Amplified RNA synthesized from limited quantities of heterogenous cDNA. Proc Natl Acad Sci USA 87: 1663-1667.
39. Walker GJ, Flores JF, Glendening JM, Lin AH, Markl ID, Fountain JW. 1998. Virtually 100% of melanoma cell lines harbor alterations at the DNA level within CDKN2A, CDKN2B, or one of their downstream targets. Genes Chromosomes Cancer 22: 157-163.
40. Xu QY, Gao Y, Liu Y, Yang WZ, Xu XY. 2008. Identification of differential gene expression profiles of radioresistant lung cancer cell line established by fractionated ionizing radiation in vitro. Chin Med J 121: 1830-1837.
41. Yan L, Borregaard N, Kjeldsen L, Moses MA. 2001. The high molecular weight urinary matrix metalloproteinase (MMP) activity is a complex of gelatinase B/MMP-9 and neutrophil gelatinaseassociated lipocalin (NGAL). Modulation of MMP-9 activity by NGAL. J Biol Chem 276: 37258-37265.
42. Yang J, Bielenberg DR, Rodig SJ, Doiron R, Clifton MC, Kung AL, Strong RK, Zurakowski D, Moses MA. 2009. Lipocalin 2 promotes breast cancer progression. Proc Natl Acad Sci USA 106: 3913-3918.
43. Yeom SY, Jang HL, Lee SJ, Kim E, Son HJ, Kim BG, Park C. 2010. Interaction of testisin with maspin and its impact on invasion and cell death resistance of cervical cancer cells. FEBS Lett 584: 1469-1475.
44. Yu W, Liu J, Xiong X, Ai Y, Wang H. 2009. Expression of MMP9 and CD147 in invasive squamous cell carcinoma of the uterine cervix and their implication. Pathol Res Pract 205: 709-715.
45. Zhang F, Pao W, Umphress SM, Jakowlew SB, Meyer AM, Dwyer-Nield LD, Nielsen LD, Takeda K, Gelfand EW, Fisher JH, Zhang L, Malkinson AM, Mason RJ. 2003. Serum levels of surfactant protein D are increased in mice with lung tumors. Cancer Res 63: 5889-5894.
46. Zhang H, Xu L, Xiao D, Xie J, Zeng H, Wang Z, Zhang X, Niu Y, Shen Z, Shen J, Wu X, Li E. 2007. Upregulation of neutrophil gelatinase-associated lipocalin in oesophageal squamous cell carcinoma: significant correlation with cell differentiation and tumor invasion. J Clin Pathol 60: 555-561.
47. Zhang XF, Zhang Y, Zhang XH, Zhou SM, Yang GG, Wang OC, Guo GL, Yang GY, Hu XQ. 2009. Clinical significance of neutrophil gelatinase-associated lipocalin (NGAL) expression in primary rectal cancer. BMC Cancer 9: 134-140.